Condition
Rhinosinusitis Acute
Total Trials
6
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 3 (2)
Trial Status
Unknown2
Completed2
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06901297Phase 3Recruiting
The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients
NCT07383493Not ApplicableNot Yet Recruiting
RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis
NCT05836935Not ApplicableUnknown
Role of Imaging in Complications of Sinusitis
NCT03729258Phase 3Unknown
Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.
NCT04703673CompletedPrimary
Sinolpan® Pharmacy Non-interventional Study - Quality of Live
NCT04642989Not ApplicableCompletedPrimary
The Effect of Facial Effleurage on Acute Rhinosinusitis
Showing all 6 trials